BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36630565)

  • 1. Blockade of CCR1 induces a phenotypic shift in macrophages and triggers a favorable antilymphoma activity.
    Le K; Sun J; Ghaemmaghami J; Smith MR; Ip WKE; Phillips T; Gupta M
    Blood Adv; 2023 Aug; 7(15):3952-3967. PubMed ID: 36630565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Behçet's disease.
    Nakano H; Kirino Y; Takeno M; Higashitani K; Nagai H; Yoshimi R; Yamaguchi Y; Kato I; Aoki I; Nakajima H
    Arthritis Res Ther; 2018 Jun; 20(1):124. PubMed ID: 29895319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis.
    Le K; Sun J; Khawaja H; Shibata M; Maggirwar SB; Smith MR; Gupta M
    Blood Adv; 2021 Jul; 5(14):2863-2878. PubMed ID: 34297045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer.
    Schmall A; Al-Tamari HM; Herold S; Kampschulte M; Weigert A; Wietelmann A; Vipotnik N; Grimminger F; Seeger W; Pullamsetti SS; Savai R
    Am J Respir Crit Care Med; 2015 Feb; 191(4):437-47. PubMed ID: 25536148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High CD206 levels in Hodgkin lymphoma-educated macrophages are linked to matrix-remodeling and lymphoma dissemination.
    Arlt A; von Bonin F; Rehberg T; Perez-Rubio P; Engelmann JC; Limm K; Reinke S; Dullin C; Sun X; Specht R; Maulhardt M; Linke F; Bunt G; Klapper W; Vockerodt M; Wilting J; Pukrop T; Dettmer K; Gronwald W; Oefner PJ; Spang R; Kube D
    Mol Oncol; 2020 Mar; 14(3):571-589. PubMed ID: 31825135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A4 enhances protumor macrophage polarization by control of PPAR-γ-dependent induction of fatty acid oxidation.
    Liu S; Zhang H; Li Y; Zhang Y; Bian Y; Zeng Y; Yao X; Wan J; Chen X; Li J; Wang Z; Qin Z
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34145030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL3/CCR1 mediates CD14
    Zhao X; Gu M; Xu X; Wen X; Yang G; Li L; Sheng P; Meng F
    Osteoarthritis Cartilage; 2020 May; 28(5):613-625. PubMed ID: 32006659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases.
    Furuichi K; Wada T; Sakai N; Iwata Y; Yoshimoto K; Shimizu M; Kobayashi K; Takasawa K; Kida H; Takeda SI; Mukaida N; Matsushima K; Yokoyama H
    Am J Nephrol; 2000; 20(4):291-9. PubMed ID: 10970982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
    Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
    J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor α- and interleukin-1β-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1.
    Wang J; Tian Y; Phillips KL; Chiverton N; Haddock G; Bunning RA; Cross AK; Shapiro IM; Le Maitre CL; Risbud MV
    Arthritis Rheum; 2013 Mar; 65(3):832-42. PubMed ID: 23233369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.
    van Attekum MHA; Terpstra S; Slinger E; von Lindern M; Moerland PD; Jongejan A; Kater AP; Eldering E
    Oncogene; 2017 Jun; 36(26):3651-3660. PubMed ID: 28192408
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Hu L; Liu Y; Kong X; Wu R; Peng Q; Zhang Y; Zhou L; Duan L
    Front Immunol; 2021; 12():658681. PubMed ID: 34093546
    [No Abstract]   [Full Text] [Related]  

  • 15. Small molecule antagonist of C-C chemokine receptor 1 (CCR1) reduces disc inflammation in the rabbit model.
    Chou PH; Chee A; Shi P; Lin CL; Zhao Y; Zhang L; An HS
    Spine J; 2020 Dec; 20(12):2025-2036. PubMed ID: 32673730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen conjugated nanoparticles reprogrammed the tumor-conditioned macrophages toward pro-immunogenic type through regulation of NADPH oxidase and p38MAPK.
    Chattopadhyay S; Roy S
    Cytokine; 2019 Jan; 113():162-176. PubMed ID: 30025979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Chemokine Receptor CCR1 Mediates Microglia Stimulated Glioma Invasion.
    Zeren N; Afzal Z; Morgan S; Marshall G; Uppiliappan M; Merritt J; Coniglio SJ
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
    Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma.
    Han Z; Wu X; Qin H; Yuan YC; Schmolze D; Su C; Zain J; Moyal L; Hodak E; Sanchez JF; Lee PP; Feng M; Rosen ST; Querfeld C
    JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Small Molecule CCR2 Antagonist Depletes Tumor Macrophages and Synergizes with Anti-PD-1 in a Murine Model of Cutaneous T-Cell Lymphoma (CTCL).
    Wu X; Singh R; Hsu DK; Zhou Y; Yu S; Han D; Shi Z; Huynh M; Campbell JJ; Hwang ST
    J Invest Dermatol; 2020 Jul; 140(7):1390-1400.e4. PubMed ID: 31945344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.